21-Mar-17 Israel's EyeYon Medical has raised USD6.5 mn to develop, test, and seek regulatory approval for its two main solutions: EndoArt, an artificial endothelial layer which can replace the need for cadaver based implants, and Hyper CLTM, a therapeutic soft contact lens. The investment was led by China-based VC Rimonci Capital and Gauss Group, with existing investors Triventures and Pontifax. [image: Globes]

20-Mar-17 Four medical specialities have taken a large number of medical tourists to Dubai in the last two years: orthopaedics, dental, eye surgery and IVF treatment. More than 298,000 medical tourists from outside the UAE visited Dubai in 2015. [image: The Middle East Magazine Online]

07-Mar-17 In 2016, the most people from CIS countries looking for treatment abroad were from Russia, Ukraine and Kazakhstan. The Russian Federation and Belarus hold 57% of the total CIS market, with similar preferred destinations. Both countries preferred Germany and Israel for treatment in 2016. Most patients going abroad went for oncology, orthopaedic, neurosurgery and ophthalmology treatment. [image: IMTJ]

10-Feb-17 Carl Zeiss Meditec reported a 6.6% increase in revenue to €280 million in the first quarter of its 2016-2017 fiscal year, compared with €262.2 million in the same quarter a year ago. In the Asia-Pacific region, revenue increased 26.6% from €83.6 million to €105.8 million, attributed to the Chinese market and Southeast Asia and India. [image: Carl Zeiss]

09-Dec-16 Carl Zeiss Meditec reported its fiscal 2016 earnings rose to EUR154 mn from EUR131 mn a year ago. The EBIT margin increased to 14.2 percent from 12.6 percent. Asia/Pacific revenue climbed 19.5 percent, mainly attributable to the Chinese market, as well as Southeast Asia and South Korea. [image: Carl Zeiss Meditec]